Oral semaglutide versus empagliflozin, sitagliptin and liraglutide in the UK: long-term cost-effectiveness analyses based on the PIONEER clinical trial programme
Your doctor should assess several factors before approving discontinuation, including your current weight status and trajectory, the presence and control of obesity-related comorbidities (type 2 diabetes, hypertension, sleep apnea, cardiovascular disease), your readiness and capacity to implement intensive lifestyle modifications, available support systems and resources, and your history of weight cycling or previous weight loss attempts
Therefore, you should discuss your out-of-pocket expenses with your health insurance provider and whether they cover Semaglutide
In people who struggle with weight, these signals can be weaker than they should be the body may not produce enough GLP-1, or the brain may not respond to it with the same sensitivity
Dehydration can exacerbate muscle stiffness and pain